TrialThe Journal of international medical research2020

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients.

Liwen Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.